|
FR21C1059I2
(en)
|
|
PHARMACEUTICAL COMPOSITIONS
|
|
DK3030262T3
(en)
|
|
COMBINED PHARMACEUTICAL COMPOSITION
|
|
DK3062849T3
(en)
|
|
MEDICATION ADMINISTRATION DEVICE
|
|
IL240290B
(en)
|
|
Pyridazinone-amides derivatives and pharmaceutical compositions containing them
|
|
IL246377A0
(en)
|
|
Oral pharmaceutical composition
|
|
ES2969363T3
(en)
|
|
Formulations
|
|
DK3043778T3
(en)
|
|
PHARMACEUTICAL COMPOSITIONS CONTAINING REFAMETINIB
|
|
ZA201604498B
(en)
|
|
Single vial vaccine formulations
|
|
FR3002736B1
(en)
|
|
ORAL NUTRITIONAL COMPOSITION AND MEDICAMENT FOR VETERINARY USE
|
|
DK3038674T3
(en)
|
|
DRUG DELIVERY DEVICES
|
|
FR3013218B1
(en)
|
|
COMPOSITION COMPRISING BUFFER-STABILIZED GELIFIED CAPSULES
|
|
HK1211021A1
(en)
|
|
2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions 2--6--9--9h-
|
|
DK3079655T3
(en)
|
|
INHALABLE MEDICINAL PRODUCTS
|
|
CL2014003283A1
(en)
|
|
Pharmaceutical formulation
|
|
DK2988733T3
(en)
|
|
PHARMACEUTICAL COMPOSITION CONTAINING CRYSTALINE MACITENTAN
|
|
DK2964193T3
(en)
|
|
Oral administration drugs
|
|
LT2983650T
(en)
|
|
Oral pharmaceutical composition comprising taste-masked n-acetylcysteine
|
|
SG11201509194SA
(en)
|
|
Radiomitigating pharmaceutical formulations
|
|
DK3079667T3
(en)
|
|
PHARMACEUTICAL DOSAGE FORMS
|
|
DK3003401T3
(en)
|
|
PHARMACEUTICAL PREPARATION
|
|
DK2954894T3
(en)
|
|
STABLE AND LYOFILIZED PHARMACEUTICAL COMPOSITION CONTAINING NOCATHIACIN
|
|
DK2897588T3
(en)
|
|
INHALABLE MEDICINAL PRODUCT
|
|
DK2994136T3
(en)
|
|
Nicotine paste formulation
|
|
DK2983747T3
(en)
|
|
drug delivery
|
|
DK2908836T3
(en)
|
|
Pharmaceutical formulation containing curcuma
|